Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report.
Oya Y; Yoshida T; Uemura T; Murakami Y; Inaba Y; Hida T
Anticancer research 38 9 5231 - 5237 2018年09月 [査読有り]
Additive effects of atezolizumab and bevacizumab plus chemotherapy for patients with non-small cell lung cancer regardless of presence of EGFR mutations, ALK rearrangements, or PD-L1 expression
Uemura T; Hida T
Trans Cancer Res 7 796 - 801 2018年08月 [査読有り]
Prevention of hypoxemia during endobronchial ultrasound-guided transbronchial needle aspiration: Usefulness of high-flow nasal cannula.
Takakuwa O; Oguri T; Asano T; Fukuda S; Kanemitsu Y; Uemura T; Ohkubo H; Takemura M; Maeno K; Ito Y; Niimi A
N. Takeda; M. Takemura; H. Hijikata; K. Fukumitsu; H. Ichikawa; T. Asano; Y. Kanemitsu; T. Uemura; O. Takakuwa; H. Ohkubo; K. Maeno; Y. Ito; T. Oguri; A. Nakamura; E. Kubota; A. Niimi AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 195 2017年
K. Sone; T. Uemura; T. Oguri; S. Fukuda; Y. Kanemitsu; O. Takakuwa; H. Ohkubo; M. Takemura; K. Maeno; Y. Ito; A. Niimi AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 195 2017年
M. Okayama; Y. Kanemitsu; T. Uemura; O. Takakuwa; H. Okubo; M. Takemura; K. Maeno; Y. Ito; T. Oguri; A. Nakamura; A. Niimi AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 195 2017年
Y. Kanemitsu; H. Ichikawa; M. Nishio; T. Asano; K. Fukumitsu; N. Takeda; M. Takemura; T. Uemura; H. Ohkubo; O. Takakuwa; K. Maeno; Y. Ito; A. Nakamura; K. Yoshikawa; A. Niimi AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 195 2017年
S. Fukuda; T. Oguri; T. Uemura; Y. Kanemitsu; O. Takakuwa; H. Ohkubo; M. Takemura; K. Maeno; A. Niimi AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 193 2016年
H. Ichikawa; O. Takakuwa; N. Takeda; K. Fukumitsu; Y. Kanemitsu; T. Uemura; H. Ohkubo; M. Takemura; K. Maeno; Y. Ito; T. Oguri; A. Niimi AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 193 2016年
O. Takakuwa; T. Oguri; M. Yokoyama; T. Uemura; E. Kunii; H. Hijikata; H. Ohkubo; M. Takemura; K. Maeno; A. Niimi EUROPEAN JOURNAL OF CANCER 49 S829 -S829 2013年09月
新たなMETおよびVEGFR阻害剤TAS-115による細胞傷害性抗癌剤耐性変化に関する検討(TAS-115, a novel MET + VEGFRs dual inhibitors, overcomes the cytotoxic anticancer drug resistance in lung cancer)
アムルビシン感受性予測因子としてのNAD(P)H:quinone oxidoreductase 1(NQO1)遺伝子多型の検討(C609T polymorphism of NAD(P)H:quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin)
Heparanase overexpression and resistance to anticancer agents
Hiroaki Ozasa; Tetsuya Oguri; Takehiro Uemura; Osamu Takakuwa; Makoto Nakao; Mikinori Miyazaki; Ken Maeno; Shigeki Sato; Ryuzo Ueda The 18th International Symposium of Hiroshima Cancer Seminar in conjunction with Three Universities' Consortium 2009年11月